FCCC Faculty Publications

Morrow M, Jordan VC. The current status of breast cancer chemoprevention: A star is born. J Surg Oncol. 2006 Dec 27;95(1) :4-5.

Wong YN, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F, Montagnet C, Armstrong K. Survival associated with treatment vs observation of localized prostate cancer in elderly men.[see comment]. JAMA. 2006 Dec 13;296(22) :2683-93.

Murphy ME, Cassimeris L. A novel cancer therapy approach targeting microtubule function.[comment]. Cancer Biology & Therapy. 2006 Dec;5(12) :1721-3.

Lin DC, Quevedo C, Brewer NE, Bell A, Testa JR, Grimes ML, Miller FD, Kaplan DR. APPL1 associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction. Molecular and Cellular Biology. 2006 Dec;26(23) :8928-8941.

Fagerlin A, Lakhani I, Lantz PM, Janz NK, Morrow M, Schwartz K, Deapen D, Salem B, Liu LH, Katz SJ. An informed decision? Breast cancer patients and their knowledge about treatment. Patient Education and Counseling. 2006 Dec;64(1-3) :303-312.

Stathakis S, Kappas C, Theodorou K, Papanikolaou N, Rosenwald JC. An inhomogeneity correction algorithm for irregular fields of high-energy photon beams based on Clarkson integration and the 3D beam subtraction method. J Appl Clin Med Phys. 2006 Winter;7(1) :1-13.

Gorin SS, Wang C, Raich P, Bowen DJ, Hay J. Decision making in cancer primary prevention and chemoprevention. Ann Behav Med. 2006 Dec;32(3) :179-87.

Fang M, Sigal LJ. Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host. J Immunol. 2006 Dec 1;177(11) :8027-36.

Astsaturov I, Cohen RB, Harari PM. EGFR-targeting monoclonal antibodies in head and neck cancer. Current Cancer Drug Targets. 2006 Dec;6(8) :691-710.

Thunnissen FB, Kerr KM, Brambilla E, Comin CE, Franklin WA, Guldhammerskov B, Westra WH, Flieder DB. EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer. European Respiratory Journal. 2006 Dec;28(6) :1186-1189.

Chatterton RT, Zujewski J, Mateo ET, Eng-Wong J, Jordan VC. Effect of raloxifene on salivary sex steroid concentrations in premenopausal women. Journal of Endocrinology. 2006 Dec;191(3) :599-604.

Ariazi EA, Lewis-Wambi JS, Gill SD, Pyle JR, Ariazi JL, Kim HR, Sharma CGN, Cordera F, Shupp HA, Li TY, Jordan VC. Emerging principles for the development of resistance to antihormonal therapy: Implications for the clinical utility of fulvestrant. Journal of Steroid Biochemistry and Molecular Biology. 2006 Dec;102(1-5) :128-138.

Young NA, Moriarty AT, Haja JC, Wilbur DC. Fine-needle aspiration biopsy of lymphoproliferative disorders--interpretations based on morphologic criteria alone: results from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology. Arch Pathol Lab Med. 2006 Dec;130(12) :1766-71.

Varsano T, Dong MQ, Niesman I, Gacula H, Lou X, Ma T, Testa JR, Yates JR 3rd, Farquhar MG. GIPC is recruited by APPL to Peripheral TrkA Endosomes and Regulates TrkA Trafficking and Signaling. Mol Cell Biol. 2006 Dec;26(23) :8942-52.

Gidding SS, Barton BA, Dorgan JA, Kimm SYS, Kwiterovich PO, Lasser NL, Robson AM, Stevens VJ, Van Horn L, Simons-Morton DG. Higher self-reported physical activity is associated with lower systolic blood pressure: The Dietary Intervention Study in Childhood (DISC). Pediatrics. 2006 Dec;118(6) :2388-2393.

Freedman GM, Anderson P, Li TY, Ross E, Swaby R, Goldstein L. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen. Cancer. 2006 Dec;107(11) :2552-2558.

Myers JS, Bellini LM, Morris JB, Graham D, Katz J, Potts JR, Weiner C, Volpp KG. Internal medicine and general surgery residents' attitudes about the ACGME duty hours regulations: a multicenter study. Academic Medicine. 2006 Dec;81(12) :1052-8.

Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M, Parker MG, Gustafsson JA. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacological Reviews. 2006 Dec;58(4) :773-781.

Ray ME, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Zelefsky MJ, Zietman AL, Kuban DA. Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure. Urology. 2006 Dec;68(6) :1257-1262.

Wetherbee SL. New weapons to snuff out kidney cancer. Nursing. 2006 Dec;36(12 Pt.1) :58-63; quiz 64.

Lin DI, Barbash O, Kumar KGS, Weber JD, Harper JW, Klein-Szanto AJP, Rustgi A, Fuchs SY, Diehl JA, Zamek-Gliszczynski MJ, Nezasa KI, Tian XB, Bridges AS, Lee K, Belinsky MG, Kruh GD, Brouwer KLR. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCFFBX4-alpha B crystallin complex Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3(-)/(-) and Abcc4(-)/(-) mice. Molecular Cell. 2006 Dec;319(3) :1485-1491.

Xu QF, Canutescu A, Obradovic Z, Dunbrack RL. ProtBuD: a database of biological unit structures of protein families and superfamilies. Bioinformatics. 2006 Dec;22(23) :2876-2882.

Park ES, Oh HJ, Kruger WD, Jung SC, Lee JS. Recombinant adeno-associated virus mediated gene transfer in a mouse model for homocystinuria. Experimental and Molecular Medicine. 2006 Dec;38(6) :652-661.

Daly MB. Tamoxifen in ductal carcinoma in situ. Semin Oncol. 2006 Dec;33(6) :647-9.

Ke JY, Gururajan M, Kumar A, Simmons A, Turcios L, Chelvarajan RL, Cohen DM, Wiest DL, Monroe JG, Bondada S. The role of MAPKs in B cell receptor-induced down-regulation of Egr-1 in immature B lymphoma cells. Journal of Biological Chemistry. 2006 Dec;281(52) :39806-39818.

Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5) :89-96.

Hershman D, Hall MJ, Wang XY, Jacobson JS, McBride R, Grann VR, Neugut AI. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006 Dec;107(11) :2581-2588.

Mahabir S, Baer DJ, Johnson LL, Hartman TJ, Dorgan JF, Campbell WS, Clevidence BA, Taylor PR. Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiology Biomarkers & Prevention. 2006 Dec;15(12) :2502-2507.

Toczylowski T, Yan H. Mechanistic analysis of a DNA end processing pathway mediated by the xenopus werner syndrome protein. J Biol Chem. 2006 Nov 3;281(44) :33198-205.

Lessin SR. A new nail in the CTCL coffin - Commentary. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2006 Nov;126(11) :2368-2369.

Carlson RW, O'Neill AM, Goldstein LJ, Sikic BI, Abramson N, Stewart JA, Davidson NE, Wood WC. A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): A trial of the eastern cooperative oncology group. Cancer Investigation. 2006 Nov;24(7) :677-681.

Cai KQ, Klein-Szanto A, Karthik D, Edelson M, Daly MB, Ozols RF, Lynch HT, Godwin AK, Xu XX. Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. Gynecologic Oncology. 2006 Nov;103(2) :719-728.

Petrocca F, Iliopoulos D, Qin HYR, Nicoloso MS, Yendamuri S, Wojcik SE, Shimizu M, Di Leva G, Vecchione A, Trapasso F, Godwin AK, Negrini M, Calin GA, Croce CM. Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer . Cancer Research. 2006 Nov;66(21) :10287-10291.

Wang L, Feigenberg S, Chen L, Pasklev K, Ma CC. Benefit of three-dimensional image-guided stereotactic localization in the hypofractionated treatment of lung cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3) :738-47.

von Mehren M. Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors. Clin Colorectal Cancer. 2006 Nov;6 Suppl 1 :S30-4.

Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnissen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M. Bronchioloalveolar carcinoma and lung adenocarcinoma: The clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. Journal of Thoracic Oncology. 2006 Nov;1(9) :S13-S19.

Wilson JJ, Mick R, Wei SJ, Rustgi AK, Markowitz SD, Hampshire M, Metz JM. Clinical trial resources on the internet must be designed to reach underrepresented minorities. Cancer J. 2006 Nov-Dec;12(6) :475-81.

Liu H, Cheng D, Weichel AK, Osipo C, Wing LK, Chen B, Louis TE, Jordan VC. Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cells. INTERNATIONAL JOURNAL OF ONCOLOGY. 2006 Nov;29(5) :1237-1246.

Fang CY, Daly MB, Miller SM, Zerr T, Malick J, Engstrom P. Coping with ovarian cancer risk: The moderating effects of perceived control on coping and adjustment. Br J Health Psychol. 2006 Nov;11(Pt 4) :561-80.

Abrahams SC, Glusker JP. Elizabeth Armstrong Wood - Obituary. Physics Today. 2006 Nov;59(11) :75-76.

Rosen DG, Cai KQ, Luthra R, Liu JS. Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma. MODERN PATHOLOGY. 2006 Nov;19(11) :1414-1420.

McDermott RS, Kloth DD, Wang H, Hudes GR, Langer CJ. Impact of zoledronic acid on renal function in patients with cancer: Clinical significance and development of a predictive model. J Support Oncol. 2006 Nov-Dec;4(10) :524-9.

Noble D, Kenna MA, Dix M, Skibbens RV, Unal E, Guacci V. Intersection between the regulators of sister chromatid cohesion establishment and maintenance in budding yeast indicates a multi-step mechanism. Cell Cycle. 2006 Nov 1;5(21) :2528-36.

Pan ZZ, Bruening W, Godwin AK. Involvement of RHO GTPases and ERK in synuclein-gamma enhanced cancer cell motility. INTERNATIONAL JOURNAL OF ONCOLOGY. 2006 Nov;29(5) :1201-1205.

Klumpp TR, Herman J, Ulicny J, Emmons RVB, Martin ME, Mangan KF. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION. 2006 Nov;38(9) :615-620.

Kouch M. Managing symptoms for a "good death". Nursing. 2006 Nov;36(11) :58-63.

Parsons SK, Shih MC, Duhamel KN, Ostroff J, Mayer DK, Austin J, Martini DR, Williams SE, Mee L, Sexson S, Kaplan SH, Redd WH, Manne S. Maternal perspectives on children's health-related quality of life during the first year after pediatric hematopoietic stem cell transplant. J Pediatr Psychol. 2006 Nov-Dec;31(10) :1100-15.

Pieretti-Vanmarcke R, Donahoe PK, Pearsall LA, Dinulescu DM, Connolly DC, Halpern EF, Seiden MV, MacLaughlin DT. Mullerian inhibiting substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America. 2006 Nov;103(46) :17426-17431.

Jordan VC. Optimising endocrine approaches for the chemoprevention of breast cancer - Beyond the Study of Tamoxifen and Raloxifene (STAR) Trial. European Journal of Cancer. 2006 Nov;42(17) :2909-2913.

Ertel A, Verghese A, Byers SW, Ochs M, Tozeren A. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells - art. no. 55. Molecular Cancer. 2006 Nov;5 :55-55.

Vilenchik MM, Knudson AG. Radiation dose-rate effects, endogenous DNA damage, and signaling resonance. Proceedings of the National Academy of Sciences of the United States of America. 2006 Nov;103(47) :17874-17879.

Bollivar DW. Recent advances in chlorophyll biosynthesis. Photosynthesis Research. 2006 Nov;90(2) :173-194.

Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RA, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS. Residual and recurrent disease following renal energy ablative therapy: A multi-institutional study. JOURNAL OF UROLOGY. 2006 Nov;176(5) :1973-1977.

Bookman MA, McMeekin DS, Fracasso PM. Sequence dependence of hematologic toxicity using carboplatin and topotecan for primary therapy of advanced epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group. Gynecologic Oncology. 2006 Nov;103(2) :473-478.

Ramcharan J, Skalka AM. Strategies for identification of HIV-1 integrase inhibitors. Future Virology. 2006 Nov;1(6) :717-731.

Ibrahim S, Langer CJ. Successful coronary artery bypass grafting after concurrent chemoradiation therapy in a patient with non-small-cell lung cancer: Case report and review of the literature. Clinical Lung Cancer. 2006 Nov;8(3) :217-219.

Balogh GA, Heulings RC, Russo J. The mismatch repair gene hPMS2 is mutated in primary breast cancer. Int J Mol Med. 2006 Nov;18(5) :853-7.

Tarn C, Godwin AK. The molecular pathogenesis of gastrointestinal stromal tumors . Clin Colorectal Cancer. 2006 Nov;6 Suppl 1 :S7-17.

Halbert RJ, Figlin RA, Atkins MB, Bernal M, Hutson TE, Uzzo RG, Bukowski RM, Khan KD, Wood CG, Dubois RW, Peacock S, Apicella C, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL. Treatment of patients with metastatic renal cell cancer - A RAND appropriateness panel. A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services. Cancer. 2006 Nov;95(10) :1448-1453.

Kim SH, Nakagawa H, Navaraj A, Naomoto Y, Klein-Szanto AJ, Rustgi AK, El-Deiry WS. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras. Cancer Res. 2006 Nov 1;66(21) :10415-24.

Mehren M. Update on the management of gastrointestinal stromal tumors. Clin Colorectal Cancer. 2006 Nov;6 Suppl 1 :S6.

Xu C, Yamamoto T, Zhou T, Aldrich CE, Frank K, Cullen JM, Jilbert AR, Mason WS. The liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphology. Virology. 2006 Oct 30;359(2) :283-94.

Bruner DW, Barsevick A, Tian C, Randall M, Mannel R, Cohn DE, Sorosky J, Spirtos NM. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study. Qual Life Res. 2006 Oct 11 :89-100.

Liu ST, Rattner JB, Jablonski SA, Yen TJ. Mapping the assembly pathways that specify formation of the trilaminar kinetochore plates in human cells. J Cell Biol. 2006 Oct 9;175(1) :41-53.

Fang CY, Ma GX, Miller SM, Tan Y, Su XF, Shive S. A brief smoking cessation intervention for Chinese and Korean American smokers. Preventive Medicine. 2006 Oct;43(4) :321-324.

Unger M. A pause, progress, and reassessment in lung cancer screening. NEW ENGLAND JOURNAL OF MEDICINE. 2006 Oct;355(17) :1822-1824.

Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg D, Pollack A. A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer. American Journal of Clinical Oncology. 2006 Oct;29(5) :458-62.

Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, Giardiello F, Rodriguez-Bigas MA, Church J, Gruber S, Offit K. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. JOURNAL OF CLINICAL ONCOLOGY. 2006 Oct;24(28) :4642-4660.

Manne SL, Andrykowski MA. Are Psychological Interventions Effective and Accepted by Cancer Patients? II. Using Empirically Supported Therapy Guidelines to Decide. Ann Behav Med. 2006 Oct;32(2) :98-103.

Andrykowski MA, Manne SL. Are psychological interventions effective and accepted by cancer patients? I. Standards and levels of evidence. Ann Behav Med. 2006 Oct;32(2) :93-7.

Manne SL, Andrykowski MA. Are psychological interventions effective and accepted by cancer patients? II. Using empirically supported therapy guidelines to decide.[see comment][comment]. Annals of Behavioral Medicine. 2006 Oct;32(2) :98-103.

Hardy RR. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr Opin Immunol. 2006 Oct;18(5) :547-55.

Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, Whittemore AS. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10) :1863-70.

Andl CD, Fargnoli BB, Okawa T, Bowser M, Takaoka M, Nakagawa H, Klein-Szanto A, Hua XX, Herlyn M, Rustgi AK. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo. CANCER RESEARCH. 2006 Oct;66(20) :9878-9885.

Balogh GA, Russo IH, Balsara BR, Russo J. Detection of chromosomal aberrations by comparative genomic hybridization during transformation of human breast epithelial cells in vitro. Int J Oncol. 2006 Oct;29(4) :877-81.

Dorgan JF, McMahon RP, Friedman LA, Van Horn L, Snetselaar LG, Kwiterovich PO Jr, Lauer RM, Lasser NL, Stevens VJ, Robson A, Cooper SF, Chandler DW, Franklin FA, Barton BA, Patterson BH, Taylor PR, Schatzkin A. Diet and sex hormones in boys: findings from the dietary intervention study in children. J Clin Endocrinol Metab. 2006 Oct;91(10) :3992-6.

Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM. Diverse effects of zinc on NF-{kappa}B and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis. 2006 Oct;27(10) :1980-90.

Zhao Q, Stoyanova R, Du SY, Sajda P, Brown TR. HiRes - a tool for comprehensive assessment and interpretation of metabolomic data. BIOINFORMATICS. 2006 Oct;22(20) :2562-2564.

Pei J, Kruger WD, Testa JR. High-resolution analysis of 9p loss in human cancer cells using single nucleotide polymorphism-based mapping arrays. Cancer Genet Cytogenet. 2006 Oct 1;170(1) :65-8.

Price RA Jr, Hannoun-Levi JM, Horwitz E, Buyyounouski M, Ruth KJ, Ma CM, Pollack A. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2) :583-92.

Price RA, Hannoun-Levi JM, Horvvitz E, Buyyounouski M, Ruth KJ, Ma CM, Pollack A. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Oct;66(2) :583-592.

Pugacheva EN, Roegiers F, Golemis EA. Interdependence of cell attachment and cell cycle signaling. Curr Opin Cell Biol. 2006 Oct;18(5) :507-15.

Ozols RF, Bookman MA, Young RC, Du Bois A, Pfisterer J, Reuss A. Intraperitoneal cisplatin therapy in ovarian cancer: Comparison with standard intravenous carboplatin and paclitaxel. GYNECOLOGIC ONCOLOGY. 2006 Oct;103(1) :1-6.

Ozols RF, Bookman MA, du Bois A, Pfisterer J, Reuss A, Young RC. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel. Gynecol Oncol. 2006 Oct;103(1) :1-6.

Pellegrino A. Looking at liver cancer. Nursing. 2006 Oct;36(10) :52-5.

Heinrich MC, Corless CL, Blanke CD, Demetri GD, Joensuu H, Roberts PJ, Eisenberg BL, von Mehren M, Fletcher CDM, Sandau K, McDougall K, Ou WB, Chen CJ, Fletcher JA. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. JOURNAL OF CLINICAL ONCOLOGY. 2006 Oct;24(29) :4764-4774.

Martin L, Schilder RJ. Novel non-cytotoxic therapy in ovarian cancer: current status and future prospects. J Natl Compr Canc Netw. 2006 Oct;4(9) :955-66.

Cohen SJ, Burtness BA. Novel targets in pancreatic cancer: focus on future paths to therapy. Expert Opin Ther Targets. 2006 Oct;10(5) :771-5.

Roberts JD, Smith MR, Feldman EJ, Cragg L, Millenson MM, Roboz GJ, Honeycutt C, Thune R, Padavic-Shaller K, Carter WH, Ramakrishnan V, Murgo AJ, Grant S. Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (Non-Hodgkin's) lymphoma. CLINICAL CANCER RESEARCH. 2006 Oct;12(19) :5809-5816.

Movsas B, Diratzouian H, Hanlon A, Cooper H, Freedman G, Konski A, Sigurdson E, Hoffman J, Meropol NJ, Weiner LM, Coia L, Lanciano R, Stein J, Kister D, Eisenberg B. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2006 Oct;29(5) :435-441.

Valicenti RK, DeSilvio M, Hanks GE, Porter A, Brereton H, Rosenthal SA, Shipley WU, Sandler HM, Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MRE, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, Whittemore AS. Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: An analysis of radiation therapy oncology group protocol 92-02 BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS LA English DT Article DE prostate cancer; prostate-specific antigen doubling time; mortality; surrogate endpoint. 2006 Oct;15(10) :1863-1870.

Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, DiPetrillo T, Khan D, Hudes R. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. AMERICAN JOURNAL OF SURGERY. 2006 Oct;192(4) :427-433.

Manne S, Lessin S. Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. J Behav Med. 2006 Oct;29(5) :419-34.

Manne SL, Andrykowski MA. Seeing the forest for the trees: a rebuttal. Ann Behav Med. 2006 Oct;32(2) :111-4.

Manne SL, Andrykowski MA. Seeing the forest for the trees: a rebuttal.[comment]. Annals of Behavioral Medicine. 2006 Oct;32(2) :111-4; discussion 115-8.

Tang Y, Poustovoitov MV, Zhao K, Garfinkel M, Canutescu A, Dunbrack R, D Adams P, Marmorstein R. Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly. NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2006 Oct;13(10) :921-929.

Gussow AM, Giordani NV, Tran RK, Imai Y, Kwiatkowski DL, Rall GF, Margolis TP, Bloom DC. Tissue-specific splicing of the herpes simplex virus type 1 latency-associated transcript (LAT) intron in LAT transgenic mice. JOURNAL OF VIROLOGY. 2006 Oct;80(19) :9414-9423.

Ma GX, Fang CY, Knauer CA, Tan Y, Shive SE. Tobacco dependence, risk perceptions and self-efficacy among Korean American smokers. Addict Behav. 2006 Oct;31(10) :1776-84.

Crino PB, Nathanson KL, Henske EP. The Tuberous Sclerosis Complex. N Engl J Med. 2006 Sep 28;355(13) :1345-1356.

Larkin JD, Bhat KL, Markham GD, Brooks BR, Schaefer Iii HF, Bock CW. Structure of the Boronic Acid Dimer and the Relative Stabilities of Its Conformers. J Phys Chem A Mol Spectrosc Kinet Environ Gen Theory. 2006 Sep 14;110(36) :10633-10642.

Gordon MS, Matei D, Aghajanian C, Matulonis UA, Brewer M, Fleming GF, Hainsworth JD, Garcia AA, Pegram MD, Schilder RJ, Cohn DE, Roman L, Derynck MK, Ng K, Lyons B, Allison DE, Eberhard DA, Pham TQ, Dere RC, Karlan BY. Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. J Clin Oncol. 2006 Sep 10;24(26) :4324-32.

Apetri AC, Maki K, Roder H, Surewicz WK. Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments. J Am Chem Soc. 2006 Sep 6;128(35) :11673-8.

Chernoff Jonathan, Peterson Jeffrey R. Methods for screening for inhibitors of autoinhibited proteins. . 2006 09/05/2006 :48 pp.

Giantonio BJ, Levy DE, O'Dwyer PJ, Meropol NJ, Catalano PJ, Benson AB. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200. ANNALS OF ONCOLOGY. 2006 Sep;17(9) :1399-1403.

Masters GA, Li SG, Dowlati A, Madajewicz S, Langer C, Schiller J, Johnson D. A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: An Eastern Cooperative Oncology Group Study (E1501). JOURNAL OF THORACIC ONCOLOGY. 2006 Sep;1(7) :673-678.

Calmont A, Wandzioch E, Tremblay KD, Minowada G, Kaestner KH, Martin GR, Zaret KS. An FGF Response Pathway that Mediates Hepatic Gene Induction in Embryonic Endoderm Cells. Dev Cell. 2006 Sep;11(3) :339-48.

Mehra R, Burtness B. Antibody therapy for early-stage breast cancer: trastuzumab adjuvant and neoadjuvant trials. Expert Opin Biol Ther. 2006 Sep;6(9) :951-62.

Barbosky L, Lawrence DK, Karunamuni G, Wikenheiser JC, Doughman YQ, Visconti RP, Burch JBE, Watanabe M. Apoptosis in the developing mouse heart. DEVELOPMENTAL DYNAMICS. 2006 Sep;235(9) :2592-2602.

Liu SX, Abdelrahim M, Khan S, Ariazi E, Jordan VC, Safe S. Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells. BIOLOGICAL CHEMISTRY. 2006 Sep;387(9) :1209-1213.

Hardy RR. B-1 B cell development. J Immunol. 2006 Sep 1;177(5) :2749-54.

Khor LY, DeSilvio M, Li RL, McDonnell TJ, Hammond MEH, Sause WT, Pilepich MV, Okunieff P, Sandler HM, Pollack A. Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Sep;66(1) :25-30.

Barsevick AM, Dudley WN, Beck SL. Cancer-related fatigue, depressive symptoms, and functional status. NURSING RESEARCH. 2006 Sep-Oct;55(5) :366-372.

Konski A, DeSilvio M, Hartsell W, Watkins-Bruner D, Coyne J, Scarantino C, JanJan N. Continuing evidence for poorer treatment outcomes for single male patients: Retreatment data from RTOG 97-14. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Sep;66(1) :229-233.

Gitelson E, Al-Saleem T, Millenson M, Lessin S, Smith MR. Cutaneous B-cell lymphoma responds to rituximab: A report of five cases and a review of the literature. Leukemia & Lymphoma. 2006 Sep;47(9) :1902-1907.

Konski AA, Pajak TF, Movsas B, Coyne J, Harris J, Gwede C, Garden A, Spencer S, Jones C, Watkins-Bruner D. Disadvantage of men living alone participating in radiation therapy oncology group head and neck trials. J Clin Oncol. 2006 Sep 1;24(25) :4177-83.

Weiss GJ, Langer C, Rosell R, Hanna N, Shepherd F, Einhorn LH, Nguyen B, Paul S, McAndrews P, Bunn PA, Kelly K. Elderly patients benefit from second-line cytotoxic chemotherapy: A subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. 2006 Sep;24(27) :4405-4411.

Jibaja-Weiss ML, Volk RJ, Granch TS, Nefe NE, Spann SJ, Aoki N, Robinson EK, Freidman LC, Beck JR. Entertainment education for informed breast cancer treatment decisions in low-literate women: development and initial evaluation of a patient decision aid. J Cancer Educ. 2006 Fall;21(3) :133-9.

Hambleton JM. Fostering a culture of respect using emotional intelligence. Pa Nurse. 2006 Sep;61(3) :14.

Bianco C, Strizzi L, Mancino M, Rehman A, Hamada S, Watanabe K, De Luca A, Jones B, Balogh G, Russo J, Mailo D, Palaia R, D'Aiuto G, Botti G, Perrone F, Salomon DS, Normanno N. Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer. Clin Cancer Res. 2006 Sep 1;12(17) :5158-5164.

Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA. Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival. Laryngoscope. 2006 Sep;116(9 Suppl Part 2) :1-13.

Arciero CA, Sigurdson ER. Liver-directed Therapies for Patients with Primary Liver Cancer and Hepatic Metastases. Curr Treat Options Oncol. 2006 Sep;7(5) :399-409.

Arciero CA, Sigurdson ER. Liver-directed therapies for hepatocellular carcinoma. J Natl Compr Canc Netw. 2006 Sep;4(8) :768-74.

Azizi AA, Gelpi E, Yang JW, Rupp B, Godwin AK, Slater C, Slavc I, Lubec G. Mass spectrometric identification of serine hydrolase OVCA2 in the medulloblastoma cell line DAOY. CANCER LETTERS. 2006 Sep;241(2) :235-249.

Bruner DW, Nolte SA, Shahin MS, Huang HQ, Sobel E, Gallup D, Cella D. Measurement of vaginal length: reliability of the vaginal sound-a Gynecologic Oncology Group Study. Int J Gynecol Cancer. 2006 Sep-Oct;16(5) :1749-55.

Levy MH, Back A, Bazargan S, Benedetti C, Billings JA, Block S, Bruera E, Carducci MA, Dy S, Eberle C, Foley KM, Harris JD, Knight SJ, Milch R, Rhiner M, Slatkin NE, Spiegel D, Sutton L, Urba S, Von Roenn JH, Weinstein SM, National Comprehensive Cancer Network. Palliative care. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2006 Sep;4(8) :776-818.

Agrawal M, Grady C, Fairclough DL, Meropol NJ, Maynard K, Emanuel EJ. Patients' decision-making process regarding participation in phase I oncology research. JOURNAL OF CLINICAL ONCOLOGY. 2006 Sep;24(27) :4479-4484.

Jibaja-Weiss ML, Volk RJ, Friedman LC, Granchi TS, Neff NE, Spann SJ, Robinson EK, Aoki N, Beck JR. Preliminary testing of a just-in-time, user-defined values clarification exercise to aid lower literate women in making informed breast cancer treatment decisions. HEALTH EXPECTATIONS. 2006 Sep;9(3) :218-231.

Bell J, Brady MF, Young RC, Lage J, Walker JL, Look KY, Rose GS, Spirtos NM. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study. GYNECOLOGIC ONCOLOGY. 2006 Sep;102(3) :432-439.

Peterson JR, Chernoff J. Src transforms in a Cool way. Nat Cell Biol. 2006 Sep;8(9) :905-7.

Crawford J, Kosmidis PA, Hirsch FR, Langer CJ. Targeting anemia in patients with lung cancer. JOURNAL OF THORACIC ONCOLOGY. 2006 Sep;1(7) :716-725.

Astsaturov I, Cohen RB, Harari P. Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer. Expert Rev Anticancer Ther. 2006 Sep;6(9) :1179-93.

Guo HT, Aldrich CE, Saputelli J, Xu CX, Mason WS. The insertion domain of the duck hepatitis B virus core protein plays a role in nucleocapsid assembly. VIROLOGY. 2006 Sep;353(2) :443-450.

Tang BQ, Kadariya Y, Murphy ME, Kruger WD. The methionine salvage pathway compound 4-methylthio-2oxobutanate causes apoptosis independent of down-regulation of ornithine decarboxylase. BIOCHEMICAL PHARMACOLOGY. 2006 Sep;72(7) :806-815.

Jordan VC. The science of selective estrogen receptor modulators: concept to clinical practice. Clin Cancer Res. 2006 Sep 1;12(17) :5010-3.

Meropol NJ, Gold PJ, Diasio RB, Andria M, Dhami M, Godfrey T, Kovatich AJ, Lund KA, Mitchell E, Schwarting R. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.[see comment]. Journal of Clinical Oncology. 2006 Sep 1;24(25) :4069-77.

Lilenbaum RC, Huber RM, Treat J, Masters G, Kaubitzsch S, Lane S, Wissel P. Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance status. Clinical Lung Cancer. 2006 Sep;8(2) :130-134.

Horwitz EM, Levy LB, Thames HD, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA. Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis. Cancer. 2006 Aug 30;107(7) :1496-502.

Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. Faseb J. 2006 Aug;20(10) :1622-34.

Morrow M, Freedman G. A Clinical Oncology Perspective on the Use of Breast MR. Magn Reson Imaging Clin N Am. 2006 Aug;14(3) :363-78.

Jordan VC. A STAR is born. Oncology (Williston Park). 2006 Aug;20(9) :1126.

Schulz S, Hyslop T, Haaf J, Bonaccorso C, Nielsen K, Witek ME, Birbe R, Palazzo J, Weinberg D, Waldman SA. A Validated Quantitative Assay to Detect Occult Micrometastases by Reverse Transcriptase-Polymerase Chain Reaction of Guanylyl Cyclase C in Patients with Colorectal Cancer. Clin Cancer Res. 2006 Aug 1;12(15) :4545-4552.

Pirruccello M, Sondermann H, Pelton JG, Pellicena P, Hoelz A, Chernoff J, Wemmer DE, Kuriyan J. A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases. JOURNAL OF MOLECULAR BIOLOGY. 2006 Aug;361(2) :312-326.

Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: Implications for biomarkers of susceptibility and cancer prevention. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 2006 Aug;1766(1) :63-78.

Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Zelefsky MJ, Pisansky TM, Elshaikh M, Horwitz EM. Comparison of biochemical failure definitions for permanent prostate brachytherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Aug;65(5) :1487-1493.

Wickborn C, Klein-Szanto AJ, Schlag PM, Braunewell KH. Correlation of visinin-like-protein-1 expression with clinicopathological features in squamous cell carcinoma of the esophagus. MOLECULAR CARCINOGENESIS. 2006 Aug;45(8) :572-581.

Lian ZL, De Luca P, Di Cristofano A. Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer. JOURNAL OF CELLULAR PHYSIOLOGY. 2006 Aug;208(2) :255-266.

Caslini C, D Capo-Chichi C, Roland IH, Nicolas E, T Yeung A, Xu XX. Histone modifications silence the GATA transcription factor genes in ovarian cancer. ONCOGENE. 2006 Aug;25(39) :5446-5461.

Russo J, Balogh GA, Heulings R, Mailo DA, Moral R, Russo PA, Sheriff F, Vanegas J, Russo IH. Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev. 2006 Aug;15(4) :306-42.

Prowse AH, Manek S, Varma R, Liu JS, Godwin AK, Maher ER, Tomlinson IPM, Kennedy SH. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. INTERNATIONAL JOURNAL OF CANCER. 2006 Aug;119(3) :556-562.

McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, Southey M, West DW, Hopper JL, Whittemore ASGroup Author kConFab Investigators. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages < 50 years. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006 Aug;15(8) :1565-1567.

Berman HM, Burley SK, Chiu W, Sali A, Adzhubei A, Bourne PE, Bryant SH, Dunbrack RL, Fidelis K, Frank J, Godzik A, Henrick K, Joachimiak A, Heymann B, Jones D, Markley JL, Moult J, Montelione GT, Orengo C, Rossmann MG, Rost B, Saibil H, Schwede T, Standley DM, Westbrook JD. Outcome of a workshop on archiving structural models of biological macromolecules. STRUCTURE. 2006 Aug;14(8) :1211-1217.

Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV Viral Load as Predictor of Mortality and Morbidity from HCC and Chronic Liver Disease in a Prospective Study. Am J Gastroenterol. 2006 Aug;101(8) :1797-803.

Chism DB, Freedman GM, Li TY, Anderson PR. Re-excision of margins before breast radiation - Diagnostic or therapeutic?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Aug;65(5) :1416-1421.

Turner DP, Cortellino S, Schupp JE, Caretti E, Loh T, Kinsella TJ, Bellacosa A. The DNA N-glycosylase MED1 exhibits preference for halogenated pyrimidines and is involved in the cytotoxicity of 5-iododeoxyuridine. Cancer Res. 2006 Aug 1;66(15) :7686-93.

Locker GY, Kaul K, Weinberg DS, Gatalica Z, Gong G, Peterman A, Lynch J, Klatzco L, Olopade OI, Bomzer CA, Newlin A, Keenan E, Tajuddin M, Knezetic J, Coronel S, Lynch HT. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features. CANCER GENETICS AND CYTOGENETICS. 2006 Aug;169(1) :33-38.

Young NA, T Moriarty A, Walsh MK, Wang E, Wilbur DC. The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria - Results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2006 Aug;130(8) :1114-1118.

College of American Pathologists, Young NA, Moriarty AT, Walsh MK, Wang E, Wilbur DC. The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria: results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. Archives of Pathology & Laboratory Medicine. 2006 Aug;130(8) :1114-8.

Konski A, Watkins-Bruner D, Feigenberg S, Hanlon A, Kulkarni S, Beck JR, Horwitz EM, Pollack A. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Aug 1;66(2) :408-15.

Bidaut G, Manion FJ, Garcia C, Ochs MF. WaveRead: automatic measurement of relative gene expression levels from microarrays using wavelet analysis. Journal of Biomedical Informatics. 2006 Aug;39(4) :379-88.

Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A. 2006 Jul 25;103(30) :11154-9.

Stathakis S, Li JS, Paskalev K, Yang J, Wang L, Ma CM. Ultra-thin TLDs for skin dose determination in high energy photon beams. Phys Med Biol. 2006 Jul 21;51(14) :3549-67.

Gronholm M, Muranen T, Toby GG, Utermark T, Hanemann CO, Golemis EA, Carpen O. A functional association between merlin and HEI10, a cell cycle regulator. ONCOGENE. 2006 Jul;25(32) :4389-4398.

Scallon BJ, Snyder LA, Anderson GM, Chen QM, Yan L, Weiner LM, Nakada MT. A review of antibody therapeutics and antibody-related technologies for oncology. JOURNAL OF IMMUNOTHERAPY. 2006 Jul-Aug;29(4) :351-364.

Tseng M, Byrne C, Evers KA, London WT, Daly MB. Acculturation and breast density in foreign-born, u.s. Chinese women. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7) :1301-5.

Feng J, Huang H, Yen TJ. CENP-F is a novel microtubule-binding protein that is essential for kinetochore attachments and affects the duration of the mitotic checkpoint delay. CHROMOSOMA. 2006 Jul;115(4) :320-329.

Ramos-Nino ME, Testa JR, Altomare DA, Pass HI, Carbone M, Bocchetta M, Mossman BT. Cellular and molecular parameters of mesothelioma. JOURNAL OF CELLULAR BIOCHEMISTRY. 2006 Jul;98(4) :723-734.

Nam JS, Kang MJ, Suchar AM, Shimamura T, Kohn EA, Michalowska AM, Jordan VC, Hirohashi S, Wakefield LM. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. CANCER RESEARCH. 2006 Jul;66(14) :7176-7184.

Hawley ST, Hofer TP, Janz NK, Fagerlin A, Schwartz K, Liu LH, Deapen D, Morrow M, Katz SJ. Correlates of between-surgeon variation in breast cancer treatments. MEDICAL CARE. 2006 Jul;44(7) :609-616.

Roach M, Hanks G, Thames H, Schellhammer P, Shipley WU, Sokol GH, Sandler H. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Jul;65(4) :965-974.

Yang DH, Fazili Z, Smith ER, Cai KQ, Klein-Szanto A, Cohen C, Horowitz IR, Xu XX. Disabled-2 Heterozygous Mice Are Predisposed to Endometrial and Ovarian Tumorigenesis and Exhibit Sex-Biased Embryonic Lethality in a p53-Null Background. Am J Pathol. 2006 Jul;169(1) :258-67.

Zschemisch NH, Liedtke C, Dierssen U, Nevzorova YA, Wustefeld T, Borlak J, Manns MP, Trautwein C. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo. Hepatology . 2006 Jul;44(1) :164-173.

Berg WA, Weinberg IN, Narayanan D, Lobrano ME, Ross E, Amodei L, Tafra L, Adler LP, Uddo J, Stein W, Levine EAGroup Author Positron Emission Mammography Work. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. BREAST JOURNAL. 2006 Jul-Aug;12(4) :309-323.

Thames HD, Kuban DA, DeSilvio ML, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL. Increasing external beam dose for T1-T2 prostate cancer: Effect on risk groups. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Jul;65(4) :975-981.

Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Ferstappen Lwmm, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, Sigurdson E, Wang H, Watson JC, Weiner LM, Meropol NJ. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clinical Colorectal Cancer. 2006 Jul;6(2) :125-132.

Hoffman JP. Letter to the editors. J Gastrointest Surg. 2006 Jul-Aug;10(7) :1095.

Luo W, Li JS, Price RA, Chen LL, Yang J, Fan JJ, Chen ZQ, McNeeley S, Xu X, Ma CM. Monte Carlo based IMRT dose verification using MLC log files and R/V outputs. MEDICAL PHYSICS. 2006 Jul;33(7) :2557-2564.

Albert KM. Open access: implications for scholarly publishing and medical libraries. J Med Libr Assoc. 2006 Jul;94(3) :253-62.

Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescut DM, Connolly D, Foster R, Dombkowski D, Preffer F, MacLaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2006 Jul;103(30) :11154-11159.

Redfern CH, Guthrie TH, Bessudo A, Densmore JJ, Holman PR, Janakiraman N, Leonard JP, Levy RL, Just RG, Smith MR, Rosenfelt FP, Wiernik PH, Carter WD, Gold DP, Melink TJ, Gutheil JC, Bender JF. Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses. J Clin Oncol. 2006 Jul 1;24(19) :3107-12.

Movsas B, Scott C, Watkins-Bruner D. Pretreatment factors significantly influence quality of life in cancer patients: A radiation therapy oncology group (RTOG) analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Jul;65(3) :830-835.

Nguyen CL, Scott WJ, Goldberg M. Radiofrequency ablation of lung malignancies. Ann Thorac Surg. 2006 Jul;82(1) :365-71.

Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SAGroup Authors Hereditary Ovarian Canc Clin Study. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006 Jul;296(2) :185-192.

Aben KK, Baglietto L, Baffoe-Bonnie A, Coebergh JW, Bailey-Wilson JE, Trink B, Verbeek AL, Schoenberg MP, Alfred Witjes J, Kiemeney LA. Segregation analysis of urothelial cell carcinoma. Eur J Cancer. 2006 Jul;42(10) :1428-33.

Ciofani M, Knowles GC, Wiest DL, von Boehmer H, Zuniga-Pflucker JC. Stage-specific and differential notch dependency at the alpha beta and gamma delta T lineage bifurcation. IMMUNITY. 2006 Jul;25(1) :105-116.

Chang JY, Moughan J, Johnstone DW, Komaki R, Goldberg M, Langer CJ, Beadle BM, Owen J, Movsas B. Surgical patterns of care in operable lung carcinoma treated with radiation. JOURNAL OF THORACIC ONCOLOGY. 2006 Jul;1(6) :526-531.

Yang HN, Bocchetta M, Kroczynska B, Elmishad AG, Chen YB, Liu ZM, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappa B-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2006 Jul;103(27) :10397-10402.

Ngo L, Nei M, Glass J. Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma. EPILEPSIA. 2006 Jul;47(7) :1237-1238.

Anderson PR. The role of radiation therapy in locally advanced endometrial cancer. Semin Radiat Oncol. 2006 Jul;16(3) :152-7.

Meropol NJ. Turning point for colorectal cancer clinical trials. JOURNAL OF CLINICAL ONCOLOGY. 2006 Jul;24(21) :3322-3324.

Karbowniczek M, Robertson GP, Henske EP. Rheb inhibits C-Raf activity and B-Raf/C-Raf heterodimerization. J Biol Chem. 2006 Jun 27;281(35) :25447-56.

Morrow M, Goldstein L. Surgery of the primary tumor in metastatic breast cancer: closing the barn door after the horse has bolted?. J Clin Oncol. 2006 Jun 20;24(18) :2694-6.

Engstrom PF. Progress in Chemoprevention: AACR Task Force Report. Clin Cancer Res. 2006 Jun 15;12(12) :3645.

Fleisher L. Telephone Quitlines: A Resource for Development, Implementation, and Evaluation. Health Promot Pract. 2006 Jun 7 .

Kittles RA, Baffoe-Bonnie AB, Moses TY, Robbins CM, Ahaghotu C, Huusko P, Pettaway C, Vijayakumar S, Bennett J, Hoke G, Mason T, Weinrich S, Trent JM, Collins FS, Mousses S, Bailey-Wilson J, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history. JOURNAL OF MEDICAL GENETICS. 2006 Jun;43(6) :507-511.

Steffen AC, Orlova A, Wikman M, Nilsson FY, Stahl S, Adams GP, Tolmachev V, Carlsson J. Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2006 Jun;33(6) :631-638.

Dell DD, Doll C. Caring for a patient with lymphedema. Nursing. 2006 Jun;36(6) :49-51.

Spidlen J, Gentleman RC, Haaland PD, Langille M, Le Meur N, Ochs MF, Schmitt C, Smith CA, Treister AS, Brinkman RR. Data standards for flow cytometry. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY. 2006 Jun;10(2) :209-214.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark NGroup Authors Nsabp. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006 Jun;295(23) :2727-2741.

Robb VA, Astrinidis A, Henske EP. Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas.[erratum appears in Mod Pathol. 2006 Jun;19(6):889]. Modern Pathology. 2006 Jun;19(6) :839-46.

Robb VA, Astrinidis A, Henske EP. Frequent of ribosomal protein S6 hyperphosphorylation in lymphangioleiomyomatosis-associated angiomyolipomas. MODERN PATHOLOGY. 2006 Jun;19(6) :839-846.

Yu Y, Fan JJ, Chen XS, Wang DR, Klein-Szanto AJ, Campbell RL, FitzGerald GA, Funk CD. Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. NATURE MEDICINE. 2006 Jun;12(6) :699-704.

Glass J. Neurologic complications of lymphoma and leukemia. Semin Oncol. 2006 Jun;33(3) :342-7.

Cianfrocca ME, Kimmel KA, Gallo J, Cardoso T, Brown MM, Hudes G, Lewis N, Weiner L, Lam GN, Brown SC, Shaw DE, Mazar AP, Cohen RB. Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours. BRITISH JOURNAL OF CANCER. 2006 Jun;94(11) :1621-1626.

Murphy ME. Polymorphic variants in the p53 pathway. Cell Death Differ. 2006 Jun;13(6) :916-20.

Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WKGroup Author Aacr Task Force Canc Prevention. Progress in chemoprevention drug development: The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer - A plan to move forward. CLINICAL CANCER RESEARCH. 2006 Jun;12(12) :3661-3697.

Gudima SO, Chang JH, Taylor JM. Restoration in vivo of defective hepatitis delta virus RNA genomes. RNA-A PUBLICATION OF THE RNA SOCIETY. 2006 Jun;12(6) :1061-1073.

Morrow M, Keeney K, Scholtens D, Wei J, Steel J, Khan SA. Selecting patients for breast-conserving therapy - The importance of lobular histology. CANCER. 2006 Jun;106(12) :2563-2568.

Dunbrack RL Jr. Sequence comparison and protein structure prediction. Curr Opin Struct Biol. 2006 Jun;16(3) :374-84.

Nagar S, Walther S, Blanchard RL. Sulfotransferase (SULT) 1A1 polymorphic variants*1,*2, and*3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. MOLECULAR PHARMACOLOGY. 2006 Jun;69(6) :2084-2092.

Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD. Sunitinib in patients with metastatic renal cell carcinoma. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006 Jun;295(21) :2516-2524.

Wakelee HA, Wang W, Schiller JH, Langer CJ, Sandler AB, Belani CP, Johnson DH, Eastern Cooperative Oncology Grp. Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. JOURNAL OF THORACIC ONCOLOGY. 2006 Jun;1(5) :441-446.

Chen ML, Xu PZ, Peng XD, Chen WS, Guzman G, Yang XM, Di Cristofano A, Pandolfi PP, Hay N. The deficiency of Akt1 is sufficient to suppress tumor development in Pten(+/-) mice. GENES & DEVELOPMENT. 2006 Jun;20(12) :1569-1574.

Nagamori I, Yomogida K, Adams PD, Sassone-Corsi P, Nojima H. Transcription factors, cAMP-responsive element modulator (CREM) and Tisp40, act in concert in postmeiotic transcriptional regulation. JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 Jun;281(22) :15073-15081.

Cherry C. Using Family History to Assess Women's Cancer Risk in a Parish Nurse Setting. Nurs Health Sci. 2006 Jun;8(2) :129.

Fan J, Li J, Chen L, Stathakis S, Luo W, Du Plessis F, Xiong W, Yang J, Ma CM. A practical Monte Carlo MU verification tool for IMRT quality assurance. Phys Med Biol. 2006 May 21;51(10) :2503-15.

Chen X, Arciero CA, Wang C, Broccoli D, Godwin AK. BRCC36 Is Essential for Ionizing Radiation-Induced BRCA1 Phosphorylation and Nuclear Foci Formation. Cancer Res. 2006 May 15;66(10) :5039-46.

Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res. 2006 May 15;66(10) :5021-8.

Tarn C, Skorobogatko YV, Taguchi T, Eisenberg B, von Mehren M, Godwin AK. Therapeutic Effect of Imatinib in Gastrointestinal Stromal Tumors: AKT Signaling Dependent and Independent Mechanisms. Cancer Res. 2006 May 15;66(10) :5477-86.

Konski A, Eisenberg D, Horwitz E, Hanlon A, Pollack A, Hanks G. Does age matter in the selection of treatment for men with early-stage prostate cancer?. Cancer. 2006 May 8;106(12) :2598-602 .

Hartman TR, Qian S, Bolinger C, Fernandez S, Schoenberg DR, Boris-Lawrie K. RNA helicase A is necessary for translation of selected messenger RNAs. Nat Struct Mol Biol. 2006 May 7;13(6) :509-16.

Bhat KL, Lai JH, Markham GD, DiJulio AM, Bock CW. Amine-catalyzed B-O-C bond formation: Mechanistic insights from density functional theory and second-order Moller-Plesset perturbation theory. ORGANOMETALLICS. 2006 May;25(10) :2427-2436.

Chen XW, Arciero CA, Wang CR, Broccoli D, Godwin AK. BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation. CANCER RESEARCH. 2006 May;66(10) :5039-5046.

Eisenberg CA, Burch JBE, Eisenberg LM. Bone marrow cells transdifferentiate to cardiomyocytes when introduced into the embryonic heart. STEM CELLS. 2006 May;24(5) :1236-1245.

Ozols RF. Challenges for chemotherapy in ovarian cancer. Ann Oncol. 2006 May;17 Suppl 5 :v181-v187.

Cantor SB, Levy LB, Cardenas-Turanzas M, Basen-Engquist K, Le T, Beck JR, Follen M. Collecting direct non-health care and time cost data: Application to screening and diagnosis of cervical cancer. MEDICAL DECISION MAKING. 2006 May-Jun;26(3) :265-272.

Chen Y, Weeks RS, Burns MR, Boorman DW, Klein-Szanto A, O'Brien TG. Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma. INTERNATIONAL JOURNAL OF CANCER. 2006 May;118(9) :2344-2349.

Roder H, Maki K, Cheng H. Early events in protein folding explored by rapid mixing methods. Chem Rev. 2006 May;106(5) :1836-61.

de Caceres II, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. CANCER RESEARCH. 2006 May;66(10) :5021-5028.

von Mehren M. Imatinib-refractory gastrointestinal stromal tumors: the clinical problem and therapeutic strategies. Curr Oncol Rep. 2006 May;8(3) :192-7.

Yoon A, Peng G, Brandenburg Y, Zollo O, Xu W, Rego E, Ruggero D. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. SCIENCE. 2006 May;312(5775) :902-906.

Jordan VC. Improvements in tumor targeting, survivorship, and chemoprevention pioneered by tamoxifen - A personal perspective. ONCOLOGY-NEW YORK. 2006 May;20(6) :553-562.

Jordan VC, Knudson AG. Improvements in tumor targeting, survivorship, and chemoprevention pioneered by tamoxifen. A personal perspective. Oncology (Williston Park). 2006 May;20(6) :553-62; discussion 567-8, 573, 577.

Chen XW, Truong TTN, Weaver J, Bove BA, Cattie K, Armstrong BA, Daly MB, Godwin AK. Intronic alterations in BRCA1 and BRCA2: Effect on mRNA splicing fidelity and expression. HUMAN MUTATION. 2006 May;27(5) :427-435.

Katz AK, Li XM, Carrell HL, Hanson BL, Langan P, Coates L, Schoenborn BP, Glusker JP, Bunick GJ. Locating active-site hydrogen atoms in D-xylose isomerase: Time-of-flight neutron diffraction. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2006 May;103(22) :8342-8347.

Smith MR, Joshi I, Jin F, Al-Saleem T. Murine model for mantle cell lymphoma. Leukemia. 2006 May;20(5) :891-3.

Langer CJ. Neglected and underrepresented subpopulations: elderly and performance status 2 patients with advanced-stage non-small-cell lung cancer. Clin Lung Cancer. 2006 May;7 Suppl 4 :S126-37.

Rogers BB. Overview of Non-Hodgkin's Lymphoma. Semin Oncol Nurs. 2006 May;22(2) :67-72.

Jordan VC. Pak up your breast tumor - and grow!. JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2006 May;98(10) :657-659.

Flieder DB, Vazque M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yankelevitz DF, Heimschke CIGroup Author Elcap Investigators. Pathologic findings of lung tumors diagnosed on baseline CT screening. AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2006 May;30(5) :606-613.

Hanna N, Bunn PA, Langer C, Einhorn L, Guthrie T, Beck T, Ansar R, Ellis P, Byrne M, Morrison M, Hariharan S, Wang B, Sandler A. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. 2006 May;24(13) :2038-2043.

Poulikakos PI, Xiao GH, Gallagher R, Jablonski S, Jhanwar SC, Testa JR. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK. Oncogene. 2006 May 1;25(44) :5960-8.

Bruner DW, Jones M, Buchanan D, Russo J. Reducing cancer disparities for minorities: A multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. JOURNAL OF CLINICAL ONCOLOGY. 2006 May;24(14) :2209-2215.

Block LM, Legrazie BA. Research to practice: Don't get lost in translation. Nurs Manage. 2006 May;37(5) :37-40.

Weaver C, Schiech L, Held-Warmkessel J, Kedziera P, Haney E, DiLullo G, Babb JS, Ruth K, Dell D, Barsevick A. Risk for unplanned hospital readmission of patients with cancer: results of a retrospective medical record review. Oncology Nursing Forum Online. 2006 May;33(3) :E44-52.

Focht SL. Spirituality, health, and healing. ONCOLOGY NURSING FORUM. 2006 May;33(3) :659-659.

Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SAGroup Author Hereditary Breast Cancer Clinical. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. INTERNATIONAL JOURNAL OF CANCER. 2006 May;118(9) :2281-2284.

Opatt D, Morrow M. The dual role of nipple preservation.[comment]. The Journal of Supportive Oncology. 2006 May;4(5) :233-4.

Ropka ME, Wenzel J, Phillips EK, Siadaty M, Philbrick JT. Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5) :840-55.

Chen X, Wang L, Fazlieva R, Kruger WD. Contrasting behaviors of mutant cystathionine beta-synthase enzymes associated with pyridoxine response. Hum Mutat. 2006 Apr 17;27(5) :474-482.

Chen X, Truong TT, Weaver J, Bove BA, Cattie K, Armstrong BA, Daly MB, Godwin AK. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum Mutat. 2006 Apr 17;27(5) :427-435.

Chang JH, Nie XC, Gudima S, Taylor J. Action of inhibitors on accumulation of processed hepatitis delta virus RNAs. JOURNAL OF VIROLOGY. 2006 Apr;80(7) :3205-3214.

He X, Kappes DJ. CD4/CD8 lineage commitment: light at the end of the tunnel?. Curr Opin Immunol. 2006 Apr;18(2) :135-42.

Manne SL, Ostroff JS, Norton TR, Fox K, Grana G, Goldstein L. Cancer-specific self-efficacy and psychosocial and functional adaptation to early stage breast cancer. Ann Behav Med. 2006 Apr;31(2) :145-54.

Pimkin M, Miller CG, Blakesley L, Oleykowski CA, Kodali NS, Yeung AT. Characterization of a periplasmic S1-like nuclease coded by the Mesorhizobium loti symbiosis island. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006 Apr;343(1) :77-84.

du Plessis FCP, Leal A, Stathakis S, Xiong W, Ma CM. Characterization of megavoltage electron beams delivered through a photon multi-leaf collimator (pMLC). PHYSICS IN MEDICINE AND BIOLOGY. 2006 Apr;51(8) :2113-2129.

Fernandez SV, Russo IH, Russo J. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. INTERNATIONAL JOURNAL OF CANCER. 2006 Apr;118(8) :1862-1868.

Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006 Apr;295(14) :1658-1667.

Ozols RF, Bookman MA, Young RC. Intraperitoneal chemotherapy for ovarian cancer. New England Journal of Medicine. 2006 Apr;354(15) :1641-1642.

Ozols RF, Vergote I. Introduction. Semin Oncol. 2006 Apr;33(2 Suppl 6) :1-2.

Ozols RF. Management of ovarian cancer - An impressive history of improvement in survival and quality of life - The Markman article reviewed. ONCOLOGY-NEW YORK. 2006 Apr;20(4) :354-+.

Balogh GA, Mailo DA, Corte MM, Roncoroni P, Nardi H, Vincent E, Martinez D, Cafasso ME, Frizza A, Ponce G, Vincent E, Barutta E, Lizarraga P, Lizarraga G, Monti C, Paolillo E, Vincent R, Quatroquio R, Grimi C, Maturi H, Aimale M, Spinsanti C, Montero H, Santiago J, Shulman L, Rivadulla M, Machiavelli M, Salum G, Cuevas MA, Picolini J, Gentili A, Gentili R, Mordoh J. Mutant p53 protein in serum could be used as a molecular marker in human breast cancer. Int J Oncol. 2006 Apr;28(4) :995-1002.

Cotteret S, Chernoff J. Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties. MOLECULAR AND CELLULAR BIOLOGY. 2006 Apr;26(8) :3215-3230.

Nebozhyn M, Loboda A, Kati L, Rook AH, Vonderheid EC, Lessin S, Berger C, Edelson R, Nichols C, Yousef M, Gudipati L, Shang ML, Showe MK, Showe LC. Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy. BLOOD. 2006 Apr;107(8) :3189-3196.

Ozols RF. Systemic therapy for ovarian cancer: current status and new treatments. Semin Oncol. 2006 Apr;33(2 Suppl 6) :3-11.

West S, Zaret K, Proudfoot NJ. Transcriptional termination sequences in the mouse serum albumin gene. Rna. 2006 Apr;12(4) :655-65.

Langer CJ. Treatment of stage I-III non-small-cell lung cancer in the elderly - The Gridelli/Maione/Rossi article reviewed. ONCOLOGY-NEW YORK. 2006 Apr;20(4) :385-+.

Emmanouilides C, Witzig TE, Gordon LI, Vo K, Wiseman GA, Flinn IW, Darif M, Schilder RJ, Molina A. Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma. LEUKEMIA & LYMPHOMA. 2006 Apr;47(4) :629-636.

He F, Fenner BJ, Godwin AK, Kwang J. White spot syndrome virus open reading frame 222 encodes a viral E3 ligase and mediates degradation of a host tumor suppressor via ubiquitination. JOURNAL OF VIROLOGY. 2006 Apr;80(8) :3884-3892.

Akagi R, Kato N, Lnoue R, Anderson KE, Jaffe EK, Sassa S. delta-Aminolevulinate dehydratase (ALAD) porphyria: The first case in North America with two novel ALAD mutations. MOLECULAR GENETICS AND METABOLISM. 2006 Apr;87(4) :329-336.

Tang L, Breinig S, Stith L, Mischel A, Tannir J, Kokona B, Fairman R, Jaffe EK. Single amino acid mutations alter the distribution of human porphobilinogen synthase quaternary structure isoforms (morpheeins). J Biol Chem. 2006 Mar 10;281(10) :6682-90.

Balkwill FR, Ashworth A, Bast RC, Berek JS, Boyd J, Disis ML, Gabra H, Gore ME, Hamilton TC, Jacobs IJ, Kaye SB, Kohn EC, Mills GB, Urban ND. 10th Biennial Helene Harris Memorial Trust Meeting. CANCER RESEARCH. 2006 Mar;66(6) :2904-2906.

Shatalova EG, Loginov VI, Bragar EA, Kazubskaja TP, Sudomoina MA, Blanchard RL, Favorova OO. Association of polymorphisms in SULTIAI and UGTIAI genes with breast cancer risk and phenotypes in Russian women. MOLECULAR BIOLOGY. 2006 Mar-Apr;40(2) :263-270.

Manne SL, Ostroff JS, Norton TR, Fox K, Goldstein L, Grana G. Cancer-related relationship communication in couples coping with early stage breast cancer. PSYCHO-ONCOLOGY. 2006 Mar;15(3) :234-247.

Daikoku T, Tranguch S, Trofimova IN, Dinulescu DM, Jacks T, Nikitin AY, Connony DC, Dey SK. Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. CANCER RESEARCH. 2006 Mar;66(5) :2527-2531.

Dadke D, Jarnik M, Pugacheva EN, Singh MK, Golemis EA. Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle. MOLECULAR BIOLOGY OF THE CELL. 2006 Mar;17(3) :1204-1217.

Block TM, Mehta AS, Blumberg BS, Dwek RA. Does rapid oligomerization of hepatitis B envelope proteins play a role in resistance to proteasome degradation and enhance chronicity?. DNA AND CELL BIOLOGY. 2006 Mar;25(3) :165-170.

Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, Cox BD, Wang W, Grammer JR, Gladson CL. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. ONCOGENE. 2006 Mar;25(12) :1721-1732.

Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJP, Visone R, De Martino L, Curcio A, Morisco C, Del Vecchio L, Baldassarre G, Arra C, Viglietto G, Indolfi C, Croce CM, Fusco A. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. CANCER RESEARCH. 2006 Mar;66(5) :2536-2543.

Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE, Zhang CF, Mayer RJ. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). JOURNAL OF CLINICAL ONCOLOGY. 2006 Mar;24(9) :1395-1403.

Ma CM, Paskalev K. In-room CT techniques for image-guided radiation therapy. Med Dosim. 2006 Spring;31(1) :30-9.

Chen Z, Ma CM, Paskalev K, Li J, Yang J, Richardson T, Palacio L, Xu X, Chen L. Investigation of MR image distortion for radiotherapy treatment planning of prostate cancer. PHYSICS IN MEDICINE AND BIOLOGY. 2006 Mar;51(6) :1393-1403.

Rumfelt LL, Zhou Y, Rowley BM, Shinton SA, Hardy RR. Lineage specification and plasticity in CD19(-) early B cell precursors. JOURNAL OF EXPERIMENTAL MEDICINE. 2006 Mar;203(3) :675-687.

Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly M, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade O, Weber BL, Rebbeck TR. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. LANCET ONCOLOGY. 2006 Mar;7(3) :223-229.

Butler LM, London SJ, Yu MC, Tseng M, Koh WP, Lee HP. On the usage of principal components analysis and multiple testing. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2006 Mar;173(5) :574-575.

Ray ME, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA. PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Mar;64(4) :1140-1150.

Zaret KS. Pancreatic beta cells: responding to the matrix. Cell Metab. 2006 Mar;3(3) :148-50.

Arciero CA, Joseph N, Watson JC, Hoffman JP. Partial stomach-partitioning gastrojejunostomy for malignant duodenal obstruction. AMERICAN JOURNAL OF SURGERY. 2006 Mar;191(3) :428-432.

Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. ONCOGENE. 2006 Mar;25(11) :1602-1611.

Disis ML, Rivkin SE, Baron A, Markman M, Connolly D, Ueland F, Kohn E, Trimble E, Berek JS. Progress in ovarian cancer research: Proceedings of the 5th biennial ovarian cancer research symposium. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2006 Mar-Apr;16(2) :463-469.

Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006 Mar 1;24(7) :1031-6.

Hartsell WF, DeSilvio M, Bruner DW, Konski A. Re: Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases - Response. JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2006 Mar;98(5) :365-365.

Pieretti-Vanmarcke R, Donahoe PK, Szotek P, Manganaro T, Lorenzen MK, Lorenzen J, Connolly DC, Halpern EF, MacLaughlin DT. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo. CLINICAL CANCER RESEARCH. 2006 Mar;12(5) :1593-1598.

Krasley E, Cooper KF, Mallory MJ, Dunbrack R, Strich R. Regulation of the oxidative stress response through Slt2p-dependent destruction of cyclin C in Saccharomyces cerevisiae. GENETICS. 2006 Mar;172(3) :1477-1486.

Bass SB, Ruzek SB, Gordon TF, Fleisher L, McKeown-Conn N, Moore D. Relationship of Internet health information use with patient behavior and self-efficacy: experiences of newly diagnosed cancer patients who contact the National Cancer Institute's Cancer Information Service. J Health Commun. 2006 Mar;11(2) :219-36.

Chen JQ, Contreras RG, Wang R, Fernandez SV, Shoshani L, Russo IH, Cereijido M, Russo J. Sodium/potasium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: a new paradigm for development of anti-breast cancer drugs?. BREAST CANCER RESEARCH AND TREATMENT. 2006 Mar;96(1) :1-15.

Dell DD. Spread the word about breast cancer. Holist Nurs Pract. 2006 Mar-Apr;20(2) :55-62.

Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. CARCINOGENESIS. 2006 Mar;27(3) :599-605.

Vernon SW, Meissner HI, Miller SM. The role of behavioral science in cancer prevention research: Planning the next steps in the collaborative process. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006 Mar;15(3) :413-415.

Ma CM, Maughan RL. Within the next decade conventional cyclotrons for proton radiotherapy will become obsolete and replaced by far less expensive machines using compact laser systems for the acceleration of the protons. Med Phys. 2006 Mar;33(3) :571-3.

Ma CMC, Maughan RL, Orton CG. Within the next decade conventional cyclotrons for proton radiotherapy will become obsolete and replaced by far less expensive machines using compact laser systems for the acceleration of the protons. MEDICAL PHYSICS. 2006 Mar;33(3) :571-573.

Khazak Vladimir, Golemis Erica A, Menon Sanjay R, Weber Lutz. Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer. . 2006 02/02/06 :49pp.

Abdelrahim M, Ariazi E, Kim K, Khan S, Barhoumi R, Burghardt R, Liu SX, Hill D, Finnell R, Wlodarczyk B, Jordan VC, Safe S. 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha. Cancer Research. 2006 Feb;66(4) :2459-2467.

Townsend DM, Findlay VJ, Fazilev F, Ogle M, Fraser J, Saavedra JE, Ji XH, Keefer LK, Tew KD. A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins. Molecular Pharmacology. 2006 Feb;69(2) :501-508.

Talamonti MS, Small W, Mulcahy MF, Wayne JD, Attaluri V, Colletti LM, Zalupski MM, Hoffman JP, Freedman GM, Kinsella TJ, Philip PA, McGinn CJ. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Annals of Surgical Oncology 13 (2): 150-158 Feb 2006. 2006 Feb;13(2) :150-8.

Jacquemin P, Yoshitomi H, Kashima Y, Rousseau GG, Lemaigre FP, Zaret KS. An endothelial-mesenchymal relay pathway regulates early phases of pancreas development. Dev Biol. 2006 Feb 1;290(1) :189-99.

Hsu TC, Chang CH, Lin MC, Liu ST, Yen TJ, Tsay GJ. Anti-CENP-H antibodies in patients with Sjogren's syndrome. Rheumatology International. 2006 Feb;26(4) :298-303.

Chen X, Arciero CA, Godwin AK. BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Expert Review of Anticancer Therapy. 2006 Feb;6(2) :187-96.

Chen XW, Arciero CA, Godwin AK. BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. EXPERT REVIEW OF ANTICANCER THERAPY. 2006 Feb;6(2) :187-196.

Locarnini S, Mason WS. Cellular and virological mechanisms of HBV drug resistance. JOURNAL OF HEPATOLOGY. 2006 Feb;44(2) :422-431.

Goldstein LJ. Controversies in adjuvant endocrine treatment of premenopausal women. Clinical Breast Cancer. 2006 Feb;6 Suppl 2 :S36-40.

Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma CMC, McNeeley SW, Buyyounouski MK, Price RA. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Feb;64(2) :518-526.

Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN, National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network. 2006 Feb;4(2) :156-76.

Young NA. Grading follicular lymphoma on fine-needle aspiration specimens - A practical approach. CANCER CYTOPATHOLOGY. 2006 Feb;108(1) :1-9.

Pugacheva EN, Golemis EA. HEF1-Aurora A interactions - Points of dialog between the cell cycle and cell attachment signaling networks. CELL CYCLE. 2006 Feb;5(4) :384-391.

Bort R, Signore M, Tremblay K, Martinez Barbera JP, Zaret KS. Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev Biol. 2006 Feb 1;290(1) :44-56.

Zayed H, McIvor RS, Wiest DL, Blazar BR. In vitro functional correction of the mutation responsible for murine severe combined immune deficiency by small fragment homologous replacement. HUMAN GENE THERAPY. 2006 Feb;17(2) :158-166.

Pfister DG, Ridge JA. Induction chemotherapy for larynx preservation: Patient selection or therapeutic effect?. JOURNAL OF CLINICAL ONCOLOGY. 2006 Feb;24(4) :540-543.

Henry LR, Goldberg M, Scott W, Konski A, Meropol NJ, Freedman G, Weiner LM, Watts P, Beard M, McLaughlin S, Cheng JD. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: A phase II report. ANNALS OF SURGICAL ONCOLOGY. 2006 Feb;13(2) :214-220.

Abdel-Wahab M, Berkey BA, Krishan A, O'Brien T, Hammond E, Roach M, Lawton C, Pilepich M, Markoe A, Pollack A. Influence of number of CAG repeats on local control in the RTOG 86-10 protocol. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2006 Feb;29(1) :14-20.

Freedman GM, Anderson PR, Li JS, Eisenberg DF, Hanlon AL, Wang L, Nicolaou N. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2006 Feb;29(1) :66-70.

Longacre TA, Ennis M, Quenneville LA, Bane AL, Bleiweiss IJ, Carter BA, Catelano E, Hendrickson MR, Hibshoosh H, Layfield LJ, Memeo L, Wu H, O'Malley FP. Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Modern Pathology. 2006 Feb;19(2) :195-207.

Arif JM, Dresler C, Clapper ML, Gairola CG, Srinivasan C, Lubet RA, Gupta RC. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens. CHEMICAL RESEARCH IN TOXICOLOGY. 2006 Feb;19(2) :295-299.

Fan JS, Matsumoto Y, Wilson DM. Nucleotide sequence and DNA secondary structure, as well as replication protein A, modulate the single-stranded abasic endonuclease activity of APE1. JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 Feb;281(7) :3889-3898.

Dritschilo A, Huang CH, Rudin CM, Marshall J, Collins B, Dul JL, Zhang CB, Kumar D, Gokhale PC, Ahmad A, Ahmad I, Sherman JW, Kasid UN. Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies. CLINICAL CANCER RESEARCH. 2006 Feb;12(4) :1251-1259.

Butler LM, Koh WP, Lee HP, Tseng M, Yu MC, London SJ. Prospective study of dietary patterns and persistent cough with phlegm among Chinese Singaporeans. American Journal of Respiratory and Critical Care Medicine. 2006 Feb 1;173(3) :264-270.

Comunale MA, Lowman M, Long RE, Krakover J, Philip R, Seeholzer S, Evans AA, Hann HWL, Block TM, Mehta AS. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. JOURNAL OF PROTEOME RESEARCH. 2006 Feb;5(2) :308-315.

Lauritsen JP, Haks MC, Lefebvre JM, Kappes DJ, Wiest DL. Recent insights into the signals that control alphabeta/gammadelta-lineage fate. Immunol Rev. 2006 Feb;209 :176-90.

Kappes DJ, He X. Role of the transcription factor Th-POK in CD4:CD8 lineage commitment. Immunol Rev. 2006 Feb;209 :237-52.

ten Klooster JP, Jaffer ZM, Chernoff J, Hordijk PL. Targeting and activation of Rac1 are mediated by the exchange factor beta-Pix. JOURNAL OF CELL BIOLOGY. 2006 Feb;172(5) :759-769.

Engstrom PF, Langer CJ. The Balducci article reviewed. ONCOLOGY-NEW YORK. 2006 Feb;20(2) :144-+.

Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. Journal of Urology. 2006 Feb;175(2) :425-31.

Chang BL, Lange EM, Dimitrov L, Valis CJ, Gillanders EM, Lange LA, Wiley KE, Isaacs SD, Wiklund F, Baffoe-Bonnie A, Langefeld CD, Zheng SL, Matikainen MP, Ikonen T, Fredriksson H, Tammela T, Walsh PC, Bailey-Wilson JE, Schleutker J, Gronberg H, Cooney KA, Isaacs WB, Suh E, Trent JM, Xu JF. Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect. HUMAN GENETICS. 2006 Feb;118(6) :716-724.

Morrow M. What is the purpose of cancer staging?. BREAST. 2006 Feb;15(1) :1-2.

Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, Bookman MA, Weeks JC. The use of radiation as a component of breast conservation therapy in national comprehensive cancer network centers. Journal of Clinical Oncology. 2006 Jan 20;24(3) :361-369.

Astrinidis A, Senapedis W, Henske EP. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner. Human Molecular Genetics. 2006 Jan 15;15(2) :287-297.

McDaniel SH, Rolland JS, Feetham SL, Miller SM. "It runs in the family": Family systems concepts and genetically linked disorders. Individuals, families, and the new era of genetics : biopsychosocial perspectives. 2006 :118-138.

Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS Care. 2006 ;20(2) :253-260.

Oyama K, Okawa T, Nakagawa H, Takaoka M, Andl CD, Kim SH, Klein-Szanto A, Diehl JA, Herlyn M, El-Deiry W, Rustgi AK. AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture. ONCOGENE. 2006 16 Oct :2353-2364.

Jordan VC. Activated estrogens and antiestrogens: A 30-year journey with David Kupfer. DRUG METABOLISM REVIEWS. 2006 ;38(1-2) :117-127.

Craig Jordan V. Activated estrogens and antiestrogens: a 30-year journey with David Kupfer. Drug Metab Rev. 2006 ;38(1-2) :117-27.

Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ, Bello CL, Theuer CP, George DJ, Rini BI. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology. 2006 Jan 1;24(1) :16-24.

Pollack A. Adjuvant and salvage radiotherapy, postprostatectomy. Comprehensive textbook of genitourinary oncology. 2006 :295-304.

Vilgelm Anna, Lian Zenglin, Wang Hong, Beauparlant Stephen L, Klein-Szanto Andres, Ellenson Lora Hedrick, Di Cristofano Antonio. Akt-Mediated Phosphorylation and Activation of Estrogen Receptor a Is Required for Endometrial Neoplastic Transformation in Pten+/- Mice. Cancer Research. 2006 ;66(7) :3375-3380.

Ma GX, Tan Y, Toubbeh JI, Edwards RL, Shive SE, Siu P, Wang P, Fang CY. Asian tobacco education and cancer awareness research special population network - A model for reducing Asian American cancer health disparities. CANCER. 2006 Suppl.;107(8) :1995-2005.

Adams Gregory P, Tai Mei-Sheng, McCartney John E, Marks James D, Stafford Walter F III, Houston LL, Huston James S, Weiner Louis M. Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv Dimers. Clinical Cancer Research. 2006 ;12(5) :1599-1605.

Matsumoto Yoshihiro. Base excision repair in mammalian cells. Methods in Molecular Biology (Totowa, NJ, United States). 2006 ;314(DNA Repair Protocols (2nd Edition)) :365-375.

Matsumoto Y. Base excision repair in mammalian cells. DNA repair protocols : mammalian systems. 2006 :365-376.

Do Kim-Anh, Müller Peter, Vannucci Marina. Bayesian inference for gene expression and proteomics. . 2006 :xviii, 437 p., [12] p. of plates.

Peterson Jeffrey R, Lebensohn Andres M, Pelish Henry E, Kirschner Marc W. Biochemical Suppression of Small-Molecule Inhibitors: A Strategy to Identify Inhibitor Targets and Signaling Pathway Components. Chemistry & Biology (Cambridge, MA, United States). 2006 ;13(4) :443-452.

Maradeo ME, Eldeen MB, Badawi AF. Breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-[gamma]. New breast cancer research. 2006 :95-106.

Jared DEvans, Christoph Seeger. Cardif: A protein central to innate immunity is inactivated by the HCV NS3 serine protease. Hepatology. 2006 ;43(3) :615-617.

Jordan VC. Case Histories: Tamoxifen. Comprehensive medicinal chemistry II. 2006 ;8 :83-102.

Maradeo Marie E, Eldeen Mazen B, Badawi Alaa F. Combinational chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-g. Horizons in Cancer Research. 2006 ;36(New Breast Cancer Research) :95-109.

Wang L, Li JS, Paskalev K, Hoban P, Luo W, Chen LL, McNeeley S, Price R, Ma C. Commissioning and quality assurance of a commercial stereotactic treatment-planning system for extracranial IMRT. Journal of Applied Clinical Medical Physics. 2006 ;7(1) :21-34.

Wang Guoli, Sauder JMichael, Dunbrack Roland L Jr. Comparative modeling and structural proteomics. Structural Genomics and High Throughput Structural Biology. 2006 :109-136.

Blumberg B. Conjectures on human interactions and the origin of life.. Life as we know it.. 2006 .

Altomare D, Testa JR. Cytogenetic and molecular genetic changes in malignant mesothelioma. Malignant pleural mesothelioma. 2006 :239-250.

Altomare BA, Testa JR. Cytogenic and molecular genetic changes in malignant mesothelioma. Malignant pleural mesothelioma. 2006 :239-250.

Miller SM, Stefanek ME, Bowen DJ, Ropka ME. Decision Making in the Cancer Context: An Introduction to the Special Series. Ann Behav Med. 2006 ;32(3) :169-171.

Apicella C, Peacock SJ, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL. Determinants of preferences for genetic counselling in Jewish women. FAMILIAL CANCER. 2006 ;5(2) :159-167.

Bidaut G, Suhre K, Claverie JM, Ochs MF. Determination of strongly overlapping signaling activity from microarray data. BMC Bioinformatics. 2006 ;7 :99.

O'Regan RM, Osipo C, Ariazi E, Lee ES, Meeke K, Morris C, Bertucci A, Sarker MAB, Grigg R, Jordan VC. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice. CLINICAL CANCER RESEARCH. 2006 Part;12(7) :2255-2263.

Bosma Gayle C, Oshinsky Jennifer, Kiefer Kerstin, Nakajima Pamela B, Charan Deepshika, Congelton Cecil, Radic Marko, Bosma Melvin J. Development of Functional B Cells in a Line of SCID Mice with Transgenes Coding for Anti-Double-Stranded DNA Antibody. Journal of Immunology. 2006 ;176(2) :889-898.

Ma CM, Veltchev I, Fourkal E, Li JS, Luo W, Fan J, Lin T, Pollack A. Development of a laser-driven proton accelerator for cancer therapy. Laser Physics. 2006 ;16(4) :639-646.

Yuan Qing-an, Simmons Heidi H, Robinson Matthew K, Russeva Maria, Marasco Wayne A, Adams Gregory P. Development of engineered antibodies specific for the Muellerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Molecular Cancer Therapeutics. 2006 ;5(8) :2096-2105.

Hoffman J. Does prior adjuvant chemoradiotherapy lead to a safer pancreatoduodenectomy?. ANNALS OF SURGICAL ONCOLOGY. 2006 Jan;13(1) :7-9.

Glusker JP. Dorothy Crowfoot Hodgkin. Out of the shadows : contributions of twentieth-century women to physics. 2006 :240-261.

Glusker JP. Dorothy Crowfoot Hodgkin (1910-1994). Out of the shadows : contributions of twentieth-century women to physics. 2006 :240-261.

Jimbo M, Meyer B, Hyslop T, Cocroft J, Turner BJ, Weinberg DS, Myers RE. Effectiveness of complete diagnostic examination in clinical practice settings. Cancer Detection and Prevention. 2006 ;30(6) :545-551.

Held-Warmkessel J. Empowering nurses to advocate for iproved patient care. ONS News. 2006 ;21(8 Suppl) :53-4.

Bui CT, Nicolas E, Sallmann G, Chiotis M, Lambrinakos A, Rees K, Trounce I, Cotton RGH, Hancock L, Godwin AK, Yeung AT. Enzymatic and chemical cleavage methods to identify genetic variation. Molecular diagnostics. 2006 :41-54.

Kossenkov AV, Bidaut G, Ochs MF. Estimating celluar signaling from transcription data. Bayesian inference for gene expression and proteomics. 2006 :xviii, 437 p..

Ariazi EA, Ariazi JL, Cordera F, Jordan VC. Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem. 2006 ;6(3) :195-216.

Buzdar AU, Harvey HA, Jordan VC. Estrogen, antiestrogens and aromatase inibitors. Cancer medicine . 2006 :828-848.

Yu Jane, Henske Elizabeth Petri. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homolog enriched in brain. Cancer Research. 2006 ;66(19) :9461-9466.

Williams JK, Skirton H, Masny A. Ethics, policy, and educational issues in genetic testing. JOURNAL OF NURSING SCHOLARSHIP. 2006 ;38(2) :119-125.

Fourkal E, Velchev I, Ma CM, Smolyakov A. Evanescent wave interference and the total transparency of a warm high-density plasma slab. PHYSICS OF PLASMAS. 2006 No.;13(9) :Art..

Summers J, Litwin S. Examining the theory of error catastrophe. JOURNAL OF VIROLOGY. 2006 Jan;80(1) :20-26.

Henderson GS, van Diest PJ, Burger H, Russo J, Raman V. Expression pattern of a homeotic gene, HOXA5, in normal breast and in breast tumors. Cellular Oncology. 2006 ;28(5-6) :305-313.

Weiner Louis M. Fully Human Therapeutic Monoclonal Antibodies. Journal of Immunotherapy. 2006 ;29(1) :1-9.

Meropol NJ, Buzaglo JS, Miller SM, Sheth HR, Stearman BJ, Stanton L. Genetic and family-related issues within a complex disease model: colorectal cancer. Individuals, families, and the new era of genetics : biopsychosocial perspectives. 2006 :320-342.

Daly MB. Genetic screening and counseling for high-risk populations. Oncology : an evidence-based approach . 2006 :341-357.

Balogh Gabriela A, Heulings Rebecca, Mailo Daniel A, Russo Patricia A, Sheriff Fathima, Russo Irma H, Moral Raquel, Russo Jose. Genomic signature induced by pregnancy in the human breast. International Journal of Oncology. 2006 ;28(2) :399-410.

Young RC. Gynecologic malignancies. Harrison's endocrinology. 2006 :239-248.

Sameroff AJ, Lewis Michael, Miller SM. Handbook of developmental psychopathology. The limits of logical empiricism : selected papers of Arthur Pap. 2006 :xiii, 394 p..

Seeger Christoph, Mason William S. Hepadnavirus. Cold Spring Harbor Monograph Series. 2006 ;47(DNA Replication and Human Disease) :729-744.

Taylor John M. Hepatitis delta virus. Virology. 2006 ;344(1) :71-76.

Weeks PH. How to organize a technology transfer office. Research administration and management. 2006 :641-652.

Kedziera P, Coyle Nessa. Hydration, thirst, and nutrition. Textbook of palliative nursing. 2006 :239-248.

Matullo Christine M, Rall Glenn F. Immunological wrong turns in the face of multiple viral challenges. Future Virology. 2006 ;1(1) :37-45.

Miller Suzanne M. Individuals, families, and the new era of genetics : biopsychosocial perspectives. . 2006 :xxiv, 578 p..

Goldberg M. Invited commentary. Ann Thorac Surg. 2006 Jan;81(1) :304.

Pollack A. Is pretreatment PSA velocity associated with pro state-cancer-specific mortality rate after radiotherapy? Commentary. Nature Clinical Practice Urology. 2006 Jan;3(1) :13-13.

Ford JS, Coups EJ, Hay JL. Knowledge of colon cancer screening in a national probability sample in the United States. J Health Commun. 2006 ;11 Suppl 1 :19-35.

Wang G, Kossenkov AV, Ochs MF. LS-NMF: a modified non-negative matrix factorization algorithm utilizing uncertainty estimates. BMC Bioinformatics. 2006 ;7 :175.

Abu-Khalaf MM, Juneja V, Chung GG, Digiovanna MP, Sipples R, McGurk M, Zelterman D, Haffty B, Reiss M, Wackers FJ, Lee FA, Burtness BA. Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer. Breast Cancer Res Treat. 2006 Sept;104(3) :341-9.

Konski A, Watkins-Bruner D, Brereton H, Feigenberg S, Hanks G. Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma. Cancer. 2006 Jan 1;106(1) :51-57.

Yamasaki S, Ishikawa E, Sakuma M, Ogata K, Sakata-Sogawa K, Hiroshima M, Wiest DL, Tokunaga M, Saito T. Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development. Nature Immunology. 2006 Jan;7(1) :67-75.

Ramcharan J, Colleluori DM, Merkel G, Andrake MD, Skalka AM. Mode of inhibition of HIV-I integrase by a C-terminal domain-specific monoclonal antibody. RETROVIROLOGY . 2006 ;3 :34.

MacGregor Schafer J, Jordan VC. Models of hormone resistance in vitro and in vivo. Breast cancer research protocols. 2006 :453-478.

Schafer JM, Jordan VC. Models of hormone resistance in vitro and in vivo. Methods in molecular medicine. 2006 :453-464.

Borghaei H, Robinson MK, Weiner LM. Monoclonal antibody therapy of cancer. Immunotherapy of cancer. 2006 :487-502.

Astrinidis A, Henske EP. Mutation detection in tumor suppressor genes using archival tissue specimens. Methods Mol Med. 2006 ;126 :185-96.

Ozols RF, Vergote I. New developments in gynecologic malignancies - Introduction. SEMINARS IN ONCOLOGY. 2006 Suppl.;33(2) :S1-S2.

Langer CJ. Osteonecrosis of the jaw, a recently recognized sequela of bisphosphonate therapy: case report. Support Cancer Ther. 2006 Jan 1;3(2) :122-4.

Lango M, Chalian AA. Overview of head and neck cancer. Geriatric otolaryngology. 2006 :471-482.

Ma GX, Tan Y, Fang CY. Passive Smoke and its Effects on Asian Americans. Passing Smoking and Health Research. 2006 :297-310.

Langer CJ, Duffy K, Horwitz EM, Litwin S, Rosvold E, Schol J, Keenan E, Nicolaou N, Friedman CD, Ridge JA. Phase I Trial of Concurrent Hyperfractionated Split Course Radiotherapy (HFx RT), Cisplatin (cDDP), and Paclitaxel in Patients with Recurrent, Previously Irradiated, or Treatment-Naive Locally Advanced Upper Aerodigestive Malignancy. Cancer Invest. 2006 ;24(2) :164-73.

Hay J, Coups E, Ford J. Predictors of perceived risk for colon cancer in a national probability sample in the United States. J Health Commun. 2006 ;11 Suppl 1 :71-92.

Beacham DA, Amatangelo MD, Cukierman E. Preparation of extracellular matrices produced by cultured and primary fibroblasts. Current protocols in cell biology. 2006 :10.09.01-10.09.21.

Schnoll RA, Engstrom PF, Subramanian S, Demidov L, Wielt DB, Tighiouart M. Prevalence and correlates of tobacco use among Russian cancer patients: implications for the development of smoking cessation interventions at a cancer center in Russia. International Journal of Behavioral Medicine. 2006 ;13(1) :16-25.

Morrow M, Jordan VC. Prevention of breast cancer. Breast cancer and molecular medicine. 2006 :63-85.

Engstrom P, Clapper M. Prevention of tobacco-related cancers. Cancer Medicine 7. 2006 :354-362.

Bassi DE, Klein-Szanto A. Proprotein convertases, metalloproteases and tumor cell invasion. Regulation of carcinogenesis, angiogenesis and metastasis by the proprotein convertases (PCs) : a new potential strategy in cancer therapy. 2006 :89-106.

McDaniel SH, Rolland JS, Feetham SL, Miller SM. Psychosocial interventions with patients and families coping with genetic conditions. Individuals, families, and the new era of genetics : biopsychosocial perspectives. 2006 :173-196.

Miller SM, Daly MB, Sherman KA, Fleisher L, Buzaglo JS, Stanton L, Godwin AK, Scarpato J. Psychosocial processes in genetic risk assessment for breast cancer. Individuals, families, and the new era of genetics : biopsychosocial perspectives. 2006 :274-319.

Narra K, Borghaei H, Al-Saleem T, Hoglund M, Smith MR. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leukemia Research. 2006 Jan;30(1) :109-14.

Seeger C, Mason WS. Replication of hepadnaviruses. DNA replication in eukaryotic cells. 2006 :729-744.

Lauritsen JP, Haks MC, Lefebvre JM, Kappes DJ, Wiest DL, Chen X, Arciero CA, Godwin AK, Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN, Weiner LM, Treat J. Role of the transcription factor Th-POK in CD4:CD8 lineage commitment. . Immunol Rev. 2006 Feb Feb Feb Jan Jan-Feb Oct;209(2) :237-52..

Schor APT, Carvalho FM, Kemp C, Silva Idcg, Russo J. S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncology Reports. 2006 Jan;15(1) :3-6.

Henry EP, Peterson JR, Salvarezza SB, Rodriguez-Boulan E, Chen JL, Stamnes M, Macia E, Feng Y, Shair MD, Kirchhausen T. Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro. Nature Chemical Biology. 2006 Jan;2(1) :39-46.

Sagil Orli, Wolfson Marina, Cohen Avi, Izumchenko Eugene, Golemis Erica A, Fraifeld Vadim E. Shc proteins and brain functions: possible implications for neuroprotection. IJNN. 2006 ;3(1) :12-20.

MacFarlane AW, Campbell KS. Signal transduction in natural killer cells. Immunobiology of natural killer cell receptors. 2006 :23-58.

MacFarlane AWth, Campbell KS. Signal transduction in natural killer cells. Curr Top Microbiol Immunol. 2006 ;298 :23-57.

Sheinfeld-Gorin S, Schnoll RA. Smoking cessation. Health promotion handbook. 2006 :xvi, 447 p..

Schnoll RA, Engstrom PF, Subramanian S, Demidov L, Wielt DB. Smoking cessation counseling by Russian oncologists: opportunities for intervention in the Russian Federation. International Journal of Behavioral Medicine. 2006 ;13(1) :8-15.

Friedman E, Kotsopoulos J, Lubinski J, T Lynch H, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, D Foulkes W, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchrist D, Eng C, Offit K, Osborne M, Sun P, Narod SAGroup Author Hereditary Breast Canc Clin Study. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. BREAST CANCER RESEARCH. 2006 No.;8(2) :Art..

Zaret KS. Stability and evolution of transcriptional regulatory networks. Mol Syst Biol. 2006 ;2 :2006 0021.

Cordera F, Jordan VC. Steroid receptors and their role in the biology and control of breast cancer. Seminars in oncology. 2006 ;33 :631-641.

Latypov Ramil F, Cheng Hong, Roder Navid A, Zhang Jiaru, Roder Heinrich. Structural Characterization of an Equilibrium Unfolding Intermediate in Cytochrome c. Journal of Molecular Biology. 2006 ;357(3) :1009-1025.

Taylor JM. Structure and replication of hepatitis delta virus RNA. Curr Top Microbiol Immunol. 2006 ;307 :1-23.

Taylor J. Structure and replication of hepatitis delta virus RNA. Hepatitis delta virus. 2006 :2-23.

Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: Conceptual, design, measurement, and analysis issues. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2006 Jan;31(1) :85-95.

Ozols Robert F. Systemic therapy for avarian cancer: current status and new treatments. Seminars in Oncology. 2006 ;33(2, Suppl. 6) :S3-S11.

Jordan VC. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br J Pharmacol. 2006 Jan;147 Suppl 1 :S269-76.

Weiner LM, Borghaei H. Targeted therapies in solid tumors: Monoclonal antibodies and small molecules. Hum Antibodies. 2006 ;15(3) :103-11.

Raghavan Derek, Brecher ML, Johnson DH, Meropol NJ, Moots P, Rose P. Textbook of uncommon cancer / editors, Derek Raghavan ... [et al.]. . 2006 :xvii, 857 p..

Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, Santella RM, Hopper JL, John EM, Andrulis IL, Durocher F, Struewing JP, Easton DF, Chenevix-Trench G. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology Biomarkers & Prevention. 2006 Jan;15(1) :76-79.

Bock CW, Markham GD, Katz AK, Glusker JP. The arrangement of first- and second-shell water molecules around metal ions: effects of charge and size.. Theor. Chem. Acc.. 2006 ;115 :100-112.

Russo J, Balogh GA, Chen JQ, Fernandez SV, Fernbaugh R, Heulings R, Mailo DA, Moral R, Russo PA, Sheriff F, Vanegas JE, Wang R, Russo IH. The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Frontiers in Bioscience. 2006 Jan 1;11 :151-172.

Blumberg Baruch S. The curiosities of hepatitis B virus: Prevention, sex ratio, and demography. Proceedings of the American Thoracic Society. 2006 ;3(1) :14-20.

Jones-Bolin Susan, Zhao Hugh, Hunter Kathryn, Klein-Szanto Andres, Ruggeri Bruce. The effects of the oral, pan-VEGF-R kinase inhibitor CEP-7055 and chemotherapy in orthotopic models of glioblastoma and colon carcinoma in mice. Molecular Cancer Therapeutics. 2006 ;5(7) :1744-1753.

Hurley K, Miller SM, Rubin L, Weinberg DS. The individual facing genetic issues: Information processing, decision making, perception, and health-protective behaviors. Individuals, families, and the new era of genetics : biopsychosocial perspectives. 2006 :79-117.

Favorova OO, Favorov AV, Boiko AN, Andreewski TV, Sudomoina MA, Alekseenkov AD, Kulakova OG, Gusev EI, Parmigiani G, Ochs MF. Three allele combinations associated with Multiple Sclerosis. BMC MEDICAL GENETICS Art. . 2006 ;7 :63.

Lewis-Wambi J, Jordan VC. Treatment of postmenopausal breast cancer with Selective Estrogen Receptor Modulators (SERMs). Hormones and breast cancer in post-menopausal women. 2006 :93-106.

Henske EP. Tuberous sclerosis complex. Encyclopedia of respiratory medicine. 2006 :303-307.

Khazak V, Kato-Stankiewicz J, Tamanoi F, Golemis EA. Yeast screens for inhibitors of Ras-Raf interaction and characterization of MCP inhibitors of Ras-Raf interaction. REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY Book series title: METHODS IN ENZYMOLOGY. 2006 ;407 :612-629.

Fourkal Eugene S, Veltchev Lavor, Ma Chang Ming. Laser-accelerated ion beam and target design. . 2006 12/22/05 :40pp.

Serebriiskii Ilya, Golemis Erica A, Joung Keith J. Yeast/bacterial two-hybrid system, kit and methods of use thereof. . 2006 20050831. :37 pp.

Campbell Kerry S. Genetically modified human natural killer cell lines expressing Fc receptor for assessing efficacy of antibody against cancer or infection. . 2006 07/08/2005 :90 pp.

Cairns Paul G. Methods for detecting hypermethylated promoters of tumor suppressor genes associated with ovarian cancer using methylation-specific PCR. . 2006 9/14/2005 :28 pp.

2006 (451 publications)